Frimline Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
as on 23-10-2024
- Revenue 44.14%
(FY 2023)
- Profit 92.28%
(FY 2023)
- Ebitda 83.68%
(FY 2023)
- Net Worth 66.13%
(FY 2023)
- Total Assets 37.25%
(FY 2023)
About Frimline
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Yash Singh and Neeraj Singh serve as directors at the Company.
- CIN/LLPIN
U15130GJ2017PTC095323
- Company No.
095323
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2017
- Date of AGM
28 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Frimline Private Limited offer?
Frimline Private Limited offers a wide range of products and services, including Health Conditions, Kidney Care, Vitamins & Supplements, Mineral Supplements, Mental Wellness.
Who are the key members and board of directors at Frimline?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Singh  | Director | 01-Feb-2017 | Current |
| Neeraj Singh | Director | 01-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Frimline.
Frimline Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.14% increase. The company also saw a substantial improvement in profitability, with a 92.28% increase in profit. The company's net worth Soared by an impressive increase of 66.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frimline?
In 2023, Frimline had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Mar 2019 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Frimline?
Frimline has a workforce of 112 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frimline, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frimline's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
